Diabetic Cardiomyopathy

In large part due to an increase in age, obesity, and diabetes mellitus, heart failure and accompanying morbidity and mortality are rising alarmingly quickly. Patients with diabetes mellitus experience much worse clinical outcomes from heart failure than patients without the condition. The phrase "diabetic cardiomyopathy" refers to the existence of cardiac dysfunction in persons with diabetes mellitus in the absence of overt clinical coronary artery disease, valvular disease, and other traditional cardiovascular risk factors, such as hypertension and dyslipidaemia. Alongside the rise in diabetes mellitus, the prevalence of diabetic cardiomyopathy is also rising. Myocardial fibrosis, dysfunctional remodelling, and concomitant diastolic dysfunction are the early symptoms of diabetic cardiomyopathy. Systolic dysfunction and clinical heart failure are later symptoms.

    Related Conference of Diabetic Cardiomyopathy

    May 30-31, 2024

    6th Euro Cardiology Congress

    Vienna, Austria
    May 30-31, 2024

    39th World Congress on Heart Diseases

    Vienna, Austria
    June 20-21, 2024

    5th European Summit on Cardiology Research

    Dublin, Ireland
    July 16-17, 2024

    13th World Heart Congress

    Paris, France
    August 01-02, 2024

    38th World Congress on Heart Diseases

    Montreal, Canada
    September 16-17, 2024

    3rd Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    October 24-25, 2024

    11th International Conference on Interventional Cardiology

    Zurich, Switzerland
    October 30-31, 2024

    7th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada

    Diabetic Cardiomyopathy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in